EASL clinical practice guidelines on the management of chronic hepatitis B: The need for liver biopsy

Journal of Hepatology

Volumn 51, Issue 1, 2009, Pages 226-227

  Papatheodoridis, George V ^a   Manolakopoulos, Spilios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

CHRONIC HEPATITIS; CLINICAL PRACTICE; HEPATITIS; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LETTER; LIVER; LIVER BIOPSY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ALANINE TRANSAMINASE; BIOPSY; DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER; PRACTICE GUIDELINES AS TOPIC;

EID: 67349145735     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.02.017     Document Type: Letter

References (8)

1. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50 (2009) 227-242
2. Fattovich G. Natural history of hepatitis B. J Hepatol 39 (2003) S50-S58
3. Lok A.S.F., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
4. Papatheodoridis G.V., Manolakopoulos S., Dusheiko G., and Archimandritis A.J. Therapeutic strategies in the management of patients with chronic hepatitis B. Lancet Infect Dis 8 (2008) 167-178
5. Papatheodoridis G.V., Chrysanthos N., Hadziyannis E., Cholongitas E., and Manesis E.K. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 15 (2008) 434-441
6. Martinot-Peignoux M., Boyer N., Colombat M., Akremi R., Pham B.-N., Ollivier S., et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36 (2002) 543-548
7. Papatheodoridis G.V., Manesis E.K., Manolakopoulos S., Elefsiniotis I.S., Goulis J., Giannousis J., et al. Is there a meaningful serum HBV DNA cut-off level for therapeutic decisions in HBeAg-negative chronic hepatitis B virus infection?. Hepatology 48 (2008) 1451-1459
8. Papatheodoridis G.V., Manesis E.K., Manolakopoulos S., Elefsiniotis I.S., Goulis J., and Archimandritis A.J. HBeg-negative patients with persistently normal alanine aminotransferase levels and HBV DNA >2000 IU/mL: some concerns - reply. Hepatology 49 (2009) 705-706